Equels Thomas K 4
4 · AIM ImmunoTech Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Equels Thomas K
CEO & President
Transactions
- Purchase
Common Stock
2024-03-15$0.33/sh+75,758$25,000→ 716,455 total
4 · AIM ImmunoTech Inc. · Filed Mar 18, 2024
Common Stock